解锁治疗成功:预测躁狂的年轻人非典型抗精神病药物的延续
Xiangying Yang1, Wenbo Huang2, Li Liu1
1The First Branch, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
BMC medical informatics and decision making
|August 2, 2024
概括
机器学习模型准确地预测了儿科疯狂的一年里斯佩里持续使用的情况. 关键因素包括非精神健康问题的急诊室访问,帮助临床决策.
科学领域:
- 儿童和青少年精神病学 儿童和青少年精神病学
- 医疗保健中的机器学习
- 药理疗法 药理疗法 药理疗法
背景情况:
- 儿童和青少年的躁狂需要有效的长期治疗.
- 里斯佩里是一种非典型的抗精神病药物,用于儿科躁狂症.
- 预测治疗的延续对于管理慢性疾病至关重要.
研究的目的:
- 开发和验证机器学习模型,用于预测儿科躁狂症患者在一年内继续服用瑞斯佩里.
- 确定与治疗坚持相关的临床和社会经济变量.
主要方法:
- 利用中国国家索赔数据库对4532名患者 (年龄在4-18岁) 的索赔数据库,开始为躁狂治疗risperidone.
- 在训练 (80%) 和测试 (20%) 数据集上使用了五种机器学习方法和SuperLearner (SL) 算法.
- 使用接收器操作特征曲线 (AUC) 下面的面积来评估模型性能.
主要成果:
- 通用线性模型 (GLM) 和超级学习者 (SL) 模型表现出强大的预测性能 (AUC:0.823).
- 这两种模型都显示出出色的区分和校准.
- 临床和社会经济因素,包括非精神卫生急诊室访问,被发现具有意义.
结论:
- GLM和SL模型准确地预测了儿科躁狂和低躁狂的RISPERIDONE治疗延续情况.
- 这些预测模型可以支持抗精神病药物治疗中的基于证据的决策.
- 识别关键预测变量可以优化年轻患者的治疗策略.
相关概念视频
Mania and Antimanic Drugs: Overview
155
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Psychosis and Antipsychotic Drugs: Overview
213
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
213
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Bipolar Disorder
60
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
60
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antipsychotic Drugs: Typical and Atypical Agents
164
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
164


